Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of beta-blockade.

Sergio Fazio, Bernadette Biondi, Carlo Carella, +5

The Journal of Clinical Endocrinology & Metabolism

Diastolic DysfunctionMyocardial HypertrophyHypertensionHeart FailureMedicine +10

Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients

P. Comella, G. Frasci, P. Carnicelli, +8

British Journal of Cancer

Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: A longitudinal study

Gaetano Lombardi, N. Panza, Bernadette Biondi, +5

Journal of Endocrinological Investigation

PsychiatryPhysiologyThyroid DiseaseNeuropharmacologyThyroid Hormone +3

Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study

G. Frasci, N. Panza, P. Comella, +10

Annals of Oncology

G-csf SupportDose-finding StudyMedicineCancer ManagementGynecology +7

Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid

Luigi Mansi, P. F. Rambaldi, N. Panza, +3

European Journal of Endocrinology

Surgical OncologyEngineeringPathologyRight LungMagnetic Resonance Imaging +15

Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: A phase I study

G. Frasci, N. Panza, P. Comella, +7

Annals of Oncology

MedicinePathologyBronchial NeoplasmCancer TreatmentOncology +2

Inhibition of cyclophosphamide mutagenicity by beta-carotene.

Maria Antonietta Belisario, Rita Pecce, Claudia Battista, +2

PubMed

A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer

Secondo Lastoria, P. DʼAmico, Luigi Mansi, +7

Nuclear Medicine Communications

A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

G. Frasci, G.P. Nicolella, P. Comella, +10

British Journal of Cancer

Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patients

G. Frasci, P. Comella, N. Panza, +10

European Journal of Cancer

MedicineCancer ManagementCarboplatin–oral EtoposidePharmacologyPharmacotherapy +3